Barry Manilow has been diagnosed with lung cancer and will be postponing his January concerts. “I’m very sorry that you have to change your plans,” the “Mandy” singer wrote in a statement posted to ...

Giving immunotherapy earlier in the day can significantly extend patients' survival, compared to giving treatment later in the day, a new study of lung cancer shows. When you purchase through links on ...

OpenAI is rolling out a new version of ChatGPT Images that promises better instruction-following, more precise editing, and up to 4x faster image generation speeds. The new model, dubbed GPT Image 1.5 ...

Massachusetts health officials announced Tuesday that the state has confirmed its first case of an incurable lung disease linked to exposure to certain countertop stones. The disease is particularly ...

Markiplier, the famous YouTube creator, is preparing to release his directorial debut film, Iron Lung, a horror movie based on the video game of the same name. Not only did he direct it, but he also ...

Markiplier has officially made the leap from YouTube megastar to feature-film director with Iron Lung, his intense adaptation of the viral indie horror game. The self-funded project marks his debut as ...

After more than two years in the works, Markiplier‘s feature-film directorial debut — horror sci-fi movie “Iron Lung” — is set to open in theaters in late January 2026. Markiplier, the popular YouTube ...

Cancer screenings exist to try to detect the disease in its earlier stages, and ultimately to save lives. But screenings for lung cancer—the leading cause of cancer deaths worldwide—are narrow, and ...

CHICAGO (WLS) -- Northwestern Medicine is launching a new lung health center to help detect lung cancer at earlier ages. This comes after a new study shows the cancer is impacting young women and ...

In 2024, Kara Goodwin started feeling a pain in her arm and shoulder that wouldn’t go away. She was diagnosed with bicep tendinitis and frozen shoulder. Doctors thought the resident of Brooklyn, New ...

A Bayer drug designed to target tumors driven by a rare genetic mutation now has accelerated FDA approval, providing another treatment option for certain patients with advanced cases of lung cancer.

Just a few months after Boehringer Ingelheim broke into the oncology space with the first drug that can target a rare tumor type in patients with non-small cell lung cancer (NSCLC), the FDA has given ...